- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2157-9024
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma ; volume:7 ; number:1 ; day:24 ; month:1 ; year:2018 ; pages:1-12 ; date:1.2018
Oncogenesis ; 7, Heft 1 (24.1.2018), 1-12, 1.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Sato, Hiroki
- Contributor
-
Sakaguchi, Masakiyo
Yamamoto, Hiromasa
Tomida, Shuta
Aoe, Keisuke
Shien, Kazuhiko
Yoshioka, Takahiro
Namba, Kei
Torigoe, Hidejiro
Soh, Junichi
Tsukuda, Kazunori
Tao, Hiroyuki
Okabe, Kazunori
Miyoshi, Shinichiro
Pass, Harvey I.
Toyooka, Shinichi
SpringerLink (Online service)
- DOI
-
10.1038/s41389-017-0017-3
- URN
-
urn:nbn:de:1111-201804134593
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sato, Hiroki
- Sakaguchi, Masakiyo
- Yamamoto, Hiromasa
- Tomida, Shuta
- Aoe, Keisuke
- Shien, Kazuhiko
- Yoshioka, Takahiro
- Namba, Kei
- Torigoe, Hidejiro
- Soh, Junichi
- Tsukuda, Kazunori
- Tao, Hiroyuki
- Okabe, Kazunori
- Miyoshi, Shinichiro
- Pass, Harvey I.
- Toyooka, Shinichi
- SpringerLink (Online service)
Other Objects (12)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy